Resultados de la búsqueda 41-50 de 13419 para monoclonal antibody

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Dabrafenib and trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  3. Oncología (médica) - Ensayos clínicos

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Dabrafenib and trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Giving vemurafenib, cobimetinib, and ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Giving vemurafenib, cobimetinib, and ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Giving vemurafenib, cobimetinib, and ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal ... monoclonal antibody, and compare them with ...

  9. Ensayos clínicos - Hematología

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer ... Monoclonal B Cell Lymphocytosis (MBL) and B-Chronic Lymphocytic Leukemia (CLL) ...

  10. Hematología - Ensayos clínicos

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell ...